Zhu Liying, Ma Sisi, Jia Chunhua, Zhang Bei, Ma Zimi, Park EunHee
School of Chinese Medicine.
School of Nursing, Beijing University of Chinese Medicine.
Medicine (Baltimore). 2020 Sep 4;99(36):e22095. doi: 10.1097/MD.0000000000022095.
Surgery is the most common and effective therapy for anal fistula, while the postoperative complication, such as pain, edema, pruritus, turgescence, and exudation in surgical wound, can have serious impact on wound healing and patients' quality of life. Chinese herbal fumigant and lotion have been commonly used in postoperative treatment and achieved satisfied effect in China. However, clinical evidence-based literature of Chinese herbal fumigant and lotion for postoperative anal fistula is not sufficient. This protocol is described for a systematic review to investigate the beneficial effects.
A systematic search will be conducted in database involving PubMed, the Cochrane library, Embase, Web of Science, Google Scholar, SinoMed, China National Knowledge Infrastructure(CNKI), VIP, Wanfang Database, CiNii(National Institute of Informatics), and KISS(Koreanstudies Information Service System) from inceptions to December 31, 2019. We will include randomized controlled trials (RCT) regarding Chinese herbal fumigant and lotion in the treatment of complication in surgical wound of anal fistula. Quality of included RCTs will be assessed according to the Cochrane Handbook 5.1.0. GRADE will be used to assess the quality of evidence. The summary results will be pooled using the random-effects model or fixed-effects model according to the heterogeneity of included studies.
After peer-review, the study will be disseminated in scientific journals and conferences.
This systematic review will provide evidence for the efficacy of Chinese herbal fumigant and lotion for curing postoperative complication of anal fistula. In addition, it might provide suggestions for Chinese medicine clinical practice or guideline.
CRD42020164975.
手术是肛瘘最常见且有效的治疗方法,然而术后并发症,如疼痛、水肿、瘙痒、肿胀及手术创面渗出等,会严重影响伤口愈合及患者生活质量。中药熏蒸洗剂在术后治疗中已被广泛应用,并在中国取得了满意的效果。然而,关于中药熏蒸洗剂治疗肛瘘术后的临床循证文献并不充分。本方案旨在进行一项系统评价以探究其有益效果。
将在PubMed、Cochrane图书馆、Embase、Web of Science、谷歌学术、中国生物医学文献数据库、中国知网、维普、万方数据库、日本国立情报学研究所数据库(CiNii)及韩国研究信息服务系统(KISS)中进行系统检索,检索时间范围从各数据库建库至2019年12月31日。我们将纳入关于中药熏蒸洗剂治疗肛瘘手术创面并发症的随机对照试验(RCT)。纳入的RCT质量将依据Cochrane手册5.1.0进行评估。采用GRADE评估证据质量。根据纳入研究的异质性,汇总结果将使用随机效应模型或固定效应模型进行合并。
经过同行评审后,该研究将在科学期刊和会议上发表。
本系统评价将为中药熏蒸洗剂治疗肛瘘术后并发症的疗效提供证据。此外,它可能为中医临床实践或指南提供建议。
PROSPERO注册号:CRD42020164975。